To Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Status and phase

Completed

Phase 2

Conditions

Post-operative Pain

Treatments

Drug: 0.9% normal saline

Drug: Bupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT03958513

BSMMU/2018/12652

Details and patient eligibility

About

To evaluate the effect of wound infiltration with 0.25% Bupivacaine in laparoscopic cholecystectomy in terms of pain severity, patient satisfaction level, quality of life, hospital stay and return to job and normal activities.

Enrollment

58 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria

Patients scheduled to undergo laparoscopic cholecystectomy under general anesthesia at department of surgery and department of hepatobiliary system, BSMMU
Patients who are eligible according to ASA Ⅰ -Ⅱ
Female or male, age ≥18 years
Patients who are scheduled for same anesthetic technique and surgical procedure for laparoscopic cholecystectomy
Discharge of patient between 12 hour to 36 hour after performing procedure
Patients given consent for enrollment in study

Exclusion criteria

Patients known to be allergic to certain recommended drugs
If patients have history of psychiatric illness
Patients on chronic analgesic therapy for any other indication
Patients who are scheduled for different anesthetic technique and surgical procedure for laparoscopic cholecystectomy
Duration of surgery more than 1 hour
Patients undergoing laparoscopic cholecystectomy for complex gallbladder disease such as incidental gallbladder pancreatitis, gallstone pancreatitis, cholecystoduodenal fistula, mirizzi syndrome
Special population group such as children, pregnant woman, patients with cirrhosis, diabetics
Duration of operative procedure more than 1 hour